Vista Pharma.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE427C01021
NSEID:
BSEID: 524711

INR

12.07

0.57 (4.96%)

BSENSE

Apr 11, 12:05 PM

BSE+NSE Vol: 1.63 k

{
  "main_header": {
    "sid": 384463,
    "name": "Vista Pharma.",
    "stock_name": "Vista Pharma.",
    "full_name": "Vista Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/vista-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "12.07",
    "chg": 0.57,
    "chgp": "4.96%",
    "dir": 1,
    "prev_price": "11.50",
    "mcapval": "45.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524711,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE427C01021",
    "curr_date": "Apr 11, 12:05 PM",
    "curr_time": "01:29 AM",
    "bse_nse_vol": "1.63 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vista-pharma-384463-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vista Pharmaceuticals Ltd Sees Strong Buying Activity Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-ltd-surges-4-93-today-up-11-36-over-past-week-amid-strong-buying-activity-1661832",
        "imagepath": "",
        "date": "2025-04-01 12:15:04",
        "description": "Vista Pharmaceuticals Ltd is witnessing significant buying activity, with a notable 4.93% increase in its stock price today, contrasting sharply with the Sensex's decline of 1.60%. Over the past week, Vista has gained 11.36%, while the Sensex has fallen by 2.36%. This trend continues over the month, where Vista's performance stands at 19.89% compared to the Sensex's modest gain of 4.07%.\n\nThe stock's price summary indicates a strong opening, with a gap up, and it has consistently outperformed its sector by 6.06% today. Additionally, Vista's moving averages are higher than the 5-day, 20-day, 50-day, and 100-day averages, although it remains below the 200-day moving average, suggesting a short-term bullish trend.\n\nFactors contributing to the buying pressure may include positive sentiment in the pharmaceuticals sector, potential developments within the company, or broader market dynamics favoring microcap stoc..."
      },
      {
        "title": "Vista Pharmaceuticals Experiences Strong Buying Activity Amid Mixed Performance Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-ltd-sees-8-88-monthly-gain-despite-0-80-decline-today-amid-mixed-market-performance-1585158",
        "imagepath": "",
        "date": "2025-03-25 14:05:04",
        "description": "Vista Pharmaceuticals Ltd is currently witnessing strong buying activity, despite a slight decline of 0.80% in its one-day performance, contrasting with the Sensex's modest gain of 0.14%. Over the past week, the stock has shown a positive trend with a 1.92% increase, although this is still below the Sensex's 3.71% rise. Notably, Vista Pharmaceuticals has performed well over the past month, with an 8.88% increase compared to the Sensex's 4.69%.\n\nIn terms of longer-term performance, Vista Pharmaceuticals has faced challenges, with a 5.42% decline over the past three months and a similar drop over the past year. However, the stock has shown resilience with a 18.47% increase over the last three years, albeit underperforming the Sensex's 36.15% gain during the same period.\n\nToday's trading session opened with a gap up, and the stock's intraday high reflects the ongoing buying pressure. The stock is currently pos..."
      },
      {
        "title": "Vista Pharmaceuticals Sees Strong Buying Activity Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-ltd-surges-4-91-today-marking-10-12-gain-over-two-days-1230643",
        "imagepath": "",
        "date": "2025-03-07 09:55:44",
        "description": "Vista Pharmaceuticals Ltd is witnessing significant buying activity, with the stock rising by 4.91% today, contrasting sharply with the Sensex's decline of 0.10%. Over the past week, Vista has shown a robust performance, gaining 18.09%, while the Sensex managed only a 1.46% increase. This upward trend marks two consecutive days of gains, totaling a notable 10.12% return.\n\nIn terms of price summary, Vista Pharmaceuticals opened with a gap up and reached an intraday high, reflecting strong buyer interest. The stock's performance over the last month shows a 5.01% increase, while the Sensex has decreased by 4.62%. Despite a challenging year-to-date performance of -5.77%, Vista's recent gains indicate a potential shift in market sentiment.\n\nThe stock's current price is above its 5-day, 20-day, and 50-day moving averages, suggesting short-term bullish momentum. However, it remains below the 100-day and 200-day mo..."
      },
      {
        "title": "Vista Pharmaceuticals Sees Strong Buying Momentum Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-ltd-surges-4-96-today-outperforming-sensex-amid-increased-buying-activity-1215815",
        "imagepath": "",
        "date": "2025-03-06 10:30:06",
        "description": "Vista Pharmaceuticals Ltd is witnessing significant buying activity, with the stock rising by 4.96% today, notably outperforming the Sensex, which only increased by 0.04%. Over the past week, Vista Pharmaceuticals has shown a robust performance, gaining 8.62%, while the Sensex declined by 1.15%. This trend indicates a strong buying momentum in the microcap pharmaceutical sector.\n\nIn terms of price summary, Vista Pharmaceuticals opened with a gap up, reflecting positive market sentiment. The stock's intraday performance has been bolstered by its current standing above the 5-day and 20-day moving averages, although it remains below the 50-day, 100-day, and 200-day moving averages, suggesting mixed long-term trends.\n\nDespite a challenging year-to-date performance of -10.19%, compared to the Sensex's -5.61%, the recent buying pressure may be attributed to sector-specific developments or company-specific news th..."
      },
      {
        "title": "Vista Pharmaceuticals Faces Mixed Technical Signals Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-technical-trend-shifts-from-mildly-bearish-to-bearish-amid-mixed-signals-2-1110696",
        "imagepath": "",
        "date": "2025-02-25 10:29:17",
        "description": "Vista Pharmaceuticals, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 10.89, showing a slight increase from the previous close of 10.70. Over the past year, Vista Pharmaceuticals has faced challenges, with a notable decline of 27.50%, contrasting sharply with a 2.08% gain in the Sensex during the same period.\n\nThe technical summary indicates mixed signals across various indicators. The MACD shows a mildly bullish trend on a weekly basis but shifts to bearish on a monthly scale. The Relative Strength Index (RSI) presents a bullish signal weekly, while the monthly view shows no signal. Bollinger Bands and moving averages reflect bearish tendencies, particularly on a daily basis. The KST indicator also leans bearish on both weekly and monthly assessments.\n\nIn terms of stock perform..."
      },
      {
        "title": "Vista Pharmaceuticals Reports Stable Financial Performance for December 2024, Implications for Future Trajectory",
        "link": "https://www.marketsmojo.com/news/result-analysis/vista-pharmaceuticals-reports-flat-financial-performance-for-december-2024-997563",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/VistaPharmaceut_quaterlyResult_427203.png",
        "date": "2025-02-13 10:17:34",
        "description": "Vista Pharmaceuticals has announced its financial results for the quarter ending December 2024, revealing stable performance metrics. The company's evaluation score has remained unchanged over the past three months, indicating consistent financial standing amidst the complexities of the pharmaceutical sector. This stability may be of interest to stakeholders."
      },
      {
        "title": "Vista Pharmaceuticals Hits 52-Week Low Amidst Ongoing Market Volatility and Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-hits-52-week-low-at-rs-9-1-amid-40-17-annual-decline-461530",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/1/VistaPharmaceut_priceRelatedfactors_285146.png",
        "date": "2025-01-30 09:35:14",
        "description": "Vista Pharmaceuticals has reached a new 52-week low, reflecting significant volatility and a 40.17% decline over the past year. The company has underperformed its sector and is trading below its moving averages, indicating challenges within the pharmaceuticals industry and broader trends affecting microcap stocks."
      },
      {
        "title": "Vista Pharmaceuticals Faces Ongoing Challenges Amidst Microcap Sector Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-hits-52-week-low-declines-38-31-over-past-year-2-369617",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/1/VistaPharmaceut_priceRelatedfactors_271453.png",
        "date": "2025-01-29 11:35:13",
        "description": "Vista Pharmaceuticals is facing significant challenges in the microcap pharmaceuticals sector, with its stock nearing a 52-week low and experiencing a consecutive decline over the past three days. The company has underperformed its sector and has seen a notable decline over the past year, raising concerns about its market position."
      },
      {
        "title": "Vista Pharmaceuticals Faces Ongoing Challenges Amidst Microcap Sector Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-hits-52-week-low-declines-38-31-over-past-year-368653",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/1/VistaPharmaceut_priceRelatedfactors_271453.png",
        "date": "2025-01-29 11:35:13",
        "description": "Vista Pharmaceuticals is facing significant challenges in the microcap pharmaceuticals sector, with its stock nearing a 52-week low and experiencing a consecutive decline over the past three days. The company has underperformed its sector and has seen a notable decline over the past year, raising concerns about its market position."
      }
    ],
    "total": 3755,
    "sid": "384463",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/vista-pharmaceuticals-384463"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2025",
      "details": "Closure of Trading window",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "20-Mar-2025",
      "details": "EGM held on 20.03.2025 - Scrutinizers Report",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of EGM",
      "datetime": "20-Mar-2025",
      "details": "Outcome of the 1st Extra Ordinary General Meeting held on 20.03.2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vista Pharmaceuticals Ltd Sees Strong Buying Activity Amid Broader Market Decline

2025-04-01 12:15:04

Vista Pharmaceuticals Ltd is witnessing significant buying activity, with a notable 4.93% increase in its stock price today, contrasting sharply with the Sensex's decline of 1.60%. Over the past week, Vista has gained 11.36%, while the Sensex has fallen by 2.36%. This trend continues over the month, where Vista's performance stands at 19.89% compared to the Sensex's modest gain of 4.07%. The stock's price summary indicates a strong opening, with a gap up, and it has consistently outperformed its sector by 6.06% today. Additionally, Vista's moving averages are higher than the 5-day, 20-day, 50-day, and 100-day averages, although it remains below the 200-day moving average, suggesting a short-term bullish trend. Factors contributing to the buying pressure may include positive sentiment in the pharmaceuticals sector, potential developments within the company, or broader market dynamics favoring microcap stoc...

Vista Pharmaceuticals Experiences Strong Buying Activity Amid Mixed Performance Trends

2025-03-25 14:05:04

Vista Pharmaceuticals Ltd is currently witnessing strong buying activity, despite a slight decline of 0.80% in its one-day performance, contrasting with the Sensex's modest gain of 0.14%. Over the past week, the stock has shown a positive trend with a 1.92% increase, although this is still below the Sensex's 3.71% rise. Notably, Vista Pharmaceuticals has performed well over the past month, with an 8.88% increase compared to the Sensex's 4.69%. In terms of longer-term performance, Vista Pharmaceuticals has faced challenges, with a 5.42% decline over the past three months and a similar drop over the past year. However, the stock has shown resilience with a 18.47% increase over the last three years, albeit underperforming the Sensex's 36.15% gain during the same period. Today's trading session opened with a gap up, and the stock's intraday high reflects the ongoing buying pressure. The stock is currently pos...

Vista Pharmaceuticals Sees Strong Buying Activity Amid Broader Market Decline

2025-03-07 09:55:44

Vista Pharmaceuticals Ltd is witnessing significant buying activity, with the stock rising by 4.91% today, contrasting sharply with the Sensex's decline of 0.10%. Over the past week, Vista has shown a robust performance, gaining 18.09%, while the Sensex managed only a 1.46% increase. This upward trend marks two consecutive days of gains, totaling a notable 10.12% return. In terms of price summary, Vista Pharmaceuticals opened with a gap up and reached an intraday high, reflecting strong buyer interest. The stock's performance over the last month shows a 5.01% increase, while the Sensex has decreased by 4.62%. Despite a challenging year-to-date performance of -5.77%, Vista's recent gains indicate a potential shift in market sentiment. The stock's current price is above its 5-day, 20-day, and 50-day moving averages, suggesting short-term bullish momentum. However, it remains below the 100-day and 200-day mo...

Vista Pharmaceuticals Sees Strong Buying Momentum Amid Market Challenges

2025-03-06 10:30:06

Vista Pharmaceuticals Ltd is witnessing significant buying activity, with the stock rising by 4.96% today, notably outperforming the Sensex, which only increased by 0.04%. Over the past week, Vista Pharmaceuticals has shown a robust performance, gaining 8.62%, while the Sensex declined by 1.15%. This trend indicates a strong buying momentum in the microcap pharmaceutical sector. In terms of price summary, Vista Pharmaceuticals opened with a gap up, reflecting positive market sentiment. The stock's intraday performance has been bolstered by its current standing above the 5-day and 20-day moving averages, although it remains below the 50-day, 100-day, and 200-day moving averages, suggesting mixed long-term trends. Despite a challenging year-to-date performance of -10.19%, compared to the Sensex's -5.61%, the recent buying pressure may be attributed to sector-specific developments or company-specific news th...

Vista Pharmaceuticals Faces Mixed Technical Signals Amid Market Challenges

2025-02-25 10:29:17

Vista Pharmaceuticals, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 10.89, showing a slight increase from the previous close of 10.70. Over the past year, Vista Pharmaceuticals has faced challenges, with a notable decline of 27.50%, contrasting sharply with a 2.08% gain in the Sensex during the same period. The technical summary indicates mixed signals across various indicators. The MACD shows a mildly bullish trend on a weekly basis but shifts to bearish on a monthly scale. The Relative Strength Index (RSI) presents a bullish signal weekly, while the monthly view shows no signal. Bollinger Bands and moving averages reflect bearish tendencies, particularly on a daily basis. The KST indicator also leans bearish on both weekly and monthly assessments. In terms of stock perform...

Vista Pharmaceuticals Reports Stable Financial Performance for December 2024, Implications for Future Trajectory

2025-02-13 10:17:34

Vista Pharmaceuticals has announced its financial results for the quarter ending December 2024, revealing stable performance metrics. The company's evaluation score has remained unchanged over the past three months, indicating consistent financial standing amidst the complexities of the pharmaceutical sector. This stability may be of interest to stakeholders.

Vista Pharmaceuticals Hits 52-Week Low Amidst Ongoing Market Volatility and Decline

2025-01-30 09:35:14

Vista Pharmaceuticals has reached a new 52-week low, reflecting significant volatility and a 40.17% decline over the past year. The company has underperformed its sector and is trading below its moving averages, indicating challenges within the pharmaceuticals industry and broader trends affecting microcap stocks.

Vista Pharmaceuticals Faces Ongoing Challenges Amidst Microcap Sector Decline

2025-01-29 11:35:13

Vista Pharmaceuticals is facing significant challenges in the microcap pharmaceuticals sector, with its stock nearing a 52-week low and experiencing a consecutive decline over the past three days. The company has underperformed its sector and has seen a notable decline over the past year, raising concerns about its market position.